report (Date of earliest event reported): December 13, 2012
Registrant’s telephone number, including area code: 215-619-3600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 Other Events
On December 13, 2012, PhotoMedex, Inc. (the “Company”) issued a press release entitled “PhotoMedex Raises Fourth Quarter 2012 Revenue Forecast”, announces that it expects revenue for the fourth quarter of 2012 to increase by more than 80% year over year and be between $52 million and $54 million. This compares with previous guidance for fourth quarter revenue to increase by more than 60% over the same quarter of 2011. The Company attributes the quarterly revenue outperformance to the efficiency of holiday advertising in the consumer business segment that is yielding sales above prior forecasts, as well as better than expected results in the Company’s Physician Recurring and Professional business segments. A copy of the press release is attached as Exhibit 99.1 hereto, and is incorporated by reference herein.
ITEM 9.01 Financial Statements and Exhibits.
99.1 Press Release dated December 13, 2012 issued by PhotoMedex, Inc.
In accordance with General Instruction B.2 of Form 8-K, the information in this current report, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.
the requirements of the Securities Exchange Act of 1934, the Company has
duly caused this Current Report to be signed on its behalf by the
undersigned hereunto duly authorized.